Loading...

Becton, Dickinson and Company

BDXBNYSE
HealthcareMedical - Instruments & Supplies
$48.16
$0.66(1.39%)

Becton, Dickinson and Company BDXB Peers

See (BDXB) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Instruments & Supplies Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BDXB$48.16+1.39%13.7B7.60$6.33+2.32%
ISRG$558.21+0.05%200.1B81.97$6.81N/A
BDXA$59.24-2.24%49.1B21.44$2.76+2.32%
BDX$171.01+0.04%49B33.21$5.15+2.32%
ALC$86.94+1.16%43B38.64$2.25+0.38%
RMD$249.73-0.08%36.6B28.00$8.92+0.85%
WST$218.56+3.37%15.7B34.36$6.36+0.38%
BAX$30.15+0.58%15.5B-57.97-$0.52+2.64%
COO$71.18+5.58%14.2B34.39$2.07N/A
HOLX$63.07+0.80%14.1B26.50$2.38N/A
Showing 1 to 10 of 75 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BDXB vs ISRG Comparison

BDXB plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BDXB stands at 13.7B. In comparison, ISRG has a market cap of 200.1B. Regarding current trading prices, BDXB is priced at $48.16, while ISRG trades at $558.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BDXB currently has a P/E ratio of 7.60, whereas ISRG's P/E ratio is 81.97. In terms of profitability, BDXB's ROE is +0.06%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, BDXB is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for BDXB.

Stock Price Comparison

Loading...

Frequently Asked Questions